DSL-6B-C2 Cells

The DSL-6B/C2 cell line is derived from the DSL-6 transplantable acinar cell carcinoma of the pancreas, specifically established from a tumor model in a male Lewis rat. This model was initiated in 1986 from a primary acinar cell carcinoma that developed after intraperitoneal administration of azaserine, a potent carcinogen. The significance of this cell line stems from its origin in pancreatic cancer research, highlighting its utility in studying the biology and underlying mechanisms of pancreatic acinar cell carcinomas.

Initially, upon establishment in culture, DSL-6B/C2 cells exhibited the characteristic production of amylase, a hallmark of pancreatic exocrine function. However, this exocrine enzyme production was transient, ceasing within one to two weeks of culture. This change in phenotypic expression is notable as it suggests an adaptation to the in vitro environment, which may affect the cells’ utility in certain types of biological assays. The loss of amylase production might also reflect changes in cell differentiation or the emergence of subpopulations within the cultured cells, which could be critical for researchers focusing on the evolution of tumor cell characteristics in vitro.